Literature DB >> 9327679

Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative prognosis.

M Yasui1, A Harada, T Nonami, Y Takeuchi, K Taniguchi, A Nakao, H Takagi.   

Abstract

When multiple hepatic tumors are present, it is sometimes difficult to distinguish between metastatic and multicentric hepatocellular carcinoma (HCC). To identify the important clinicopathologic features of multicentric HCC, we evaluated the clinical characteristics of patients with multicentric HCC and examined the usefulness of surgical treatment in those patients. A total of 99 patients with multiple HCCs were classified into one of the following two groups according to whether their tumors were multicentric or metastatic: Group MO consisted of 18 patients with tumors thought to have developed synchronously from multicentric origins. Group IM consisted of 64 patients with intrahepatic metastases. In this study 18% of the patients with multiple HCCs were thought to have presented with multicentric tumors. This study revealed that synchronous multicentric HCCs often affected multiple segments of the liver and responded relatively well to partial hepatectomy of individual tumor-affected areas. To appropriately treat potentially multicentric HCC, it is important to understand the histopathologic characteristics of multicentric HCC and diagnose during preoperative and intraoperative ultra-sonography, so surgical treatment may be useful.

Entities:  

Mesh:

Year:  1997        PMID: 9327679     DOI: 10.1007/s002689900318

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  7 in total

1.  Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.

Authors:  Ming-Da Wang; Chao Li; Jun Li; Wan-Guang Zhang; Wei-Qin Jiang; Jiong-Jie Yu; Hao Xing; Han Wu; Jun Han; Zhen-Li Li; Xin-Fei Xu; Ting-Hao Chen; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Yong-Yi Zeng; Yao-Ming Zhang; Timothy M Pawlik; Wan Yee Lau; Meng-Chao Wu; Jia-Mei Yang; Feng Shen; Tian Yang
Journal:  Oncologist       Date:  2019-05-24

2.  The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers.

Authors:  Ying Hou; Qifei Zou; Ruiliang Ge; Feng Shen; Yizheng Wang
Journal:  Cell Res       Date:  2011-08-23       Impact factor: 25.617

3.  Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.

Authors:  Qiang Li; Jian Wang; Jonathan T Juzi; Yan Sun; Hong Zheng; Yunlong Cui; Haixin Li; Xishan Hao
Journal:  J Gastrointest Surg       Date:  2008-07-16       Impact factor: 3.452

4.  Tumor grade may be used to select patients with multifocal hepatocellular carcinoma for resection.

Authors:  Samantha M Ruff; Luke D Rothermel; Laurence P Diggs; Michael M Wach; Reed I Ayabe; Sean P Martin; David Boulware; Daniel Anaya; Jeremy L Davis; John E Mullinax; Jonathan M Hernandez
Journal:  HPB (Oxford)       Date:  2019-11-13       Impact factor: 3.647

5.  The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker.

Authors:  Xianwei Zhang; Hu Zhou; Wei Jing; Ping Luo; Shili Qiu; Xuefang Liu; Man Zhu; Chunzi Liang; Mingxia Yu; Jiancheng Tu
Journal:  Dis Markers       Date:  2018-01-23       Impact factor: 3.434

6.  Clinical Features and Clonal Origin of Diffuse Hepatocellular Carcinoma.

Authors:  Zheng-Lu Wang; Lu-Zhou Zhang; Yu-Liang Wang; Wei-Ping Zheng; Hong Zheng
Journal:  Chin Med J (Engl)       Date:  2018-05-05       Impact factor: 2.628

7.  Hepatectomy plus adjuvant transcatheter arterial chemoembolization improves the survival rate of patients with multicentric occurrence of hepatocellular carcinoma.

Authors:  Da Xu; Xiaofeng Liu; Lijun Wang; Baocai Xing
Journal:  Oncol Lett       Date:  2018-08-20       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.